In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory ...

97% of healthcare workers preferred Tropis® ID for routine immunization. Vaccinators noted Tropis is easy to operate, resulted in less perceived child discomfort, and elicits a positive caregiver ...

Institut Pasteur de Dakar has opened a new front in its push to enable low-cost access to vaccines, teaming up with the medtech company Satio to advance candidates based on intradermal delivery patch ...

On Tuesday, Riverside County received 690 vials of the monkeypox vaccine from the California Department of Public Health. But as monkeypox cases continue to grow in the Coachella Valley, there’s not ...

One solution proposed to the current shortage of monkeypox vaccine has been to consider 'dose sparing' to make supplies stretch further. This involves using one vial of the Imvanex/Jynneos vaccine, ...

Jessica was a writer on the Wellness team, with a focus on health technology, eye care, nutrition and finding new approaches to chronic health problems. The monkeypox vaccine is available to people at ...

People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...

The transition from Monkeypox Inoculation Plan A to Monkeypox Inoculation Plan B has been a smashing success—at least, if you ask federal officials. Just a few weeks ago, the U.S. had nowhere near ...

The US is switching to a skin-deep monkeypox vaccine strategy, to save on supplies. Using this new technique, there should be "enough" shots available to vaccinate everyone at risk, federal officials ...

The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...

The US Food and Drug Administration (FDA) today authorized intradermal administration of the Jynneos vaccine for the treatment of monkeypox. The process, approved specifically for high-risk patients, ...